Genesis Biotechgroup, a member of the Genesis Biotechnology Group (GBG), is a cutting-edge life science company based in Hamilton, New Jersey. They are dedicated to discovering and advancing innovative new medicines in the fields of immuno-oncology and metabolic disease, with the goal of addressing unmet medical needs. Genesis Biotechgroup has a team of skilled biologists and chemists who specialize in identifying validated small molecule drug targets across therapeutic areas.

They utilize state-of-the-art screening technology and high-throughput assays to identify novel chemotypes, which then progress into in vivo studies. Furthermore, they collaborate with partners for clinical and commercial development to bring their products to patients. Genesis Biotechgroup's primary focus is on immuno-oncology targets that harness the immune system to treat cancer, as well as metabolic pathways involved in NASH biology.

With their expertise in assay development, protein engineering, structural biology, medicinal chemistry, and in vivo models, they strive to improve patients' lives by discovering therapeutic compounds against biological targets